Product
AP026
1 clinical trial
2 indications
Indication
Diabetes MellitusIndication
Type 2Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate AP026 (TQA2226) for Injection in Adult Subjects After Single/Multiple Administration.Status: Recruiting, Estimated PCD: 2024-06-01